Unit of Clinical Pharmacology, Department of Clinical Sciences, University of Milan, Via GB Grassi 74, 20157 Milan, Italy.
Pediatrics. 2010 Nov;126(5):e1237-41. doi: 10.1542/peds.2010-0419. Epub 2010 Oct 18.
Atrial fibrillation (AF) is the most common rhythm disorder observed in clinical practice. Several case reports and case-control studies have associated this condition with the use of systemic corticosteroids. However, to our knowledge, no case of AF induced by inhaled corticosteroids has been reported in the literature. We describe here the case of a 15-year-old boy who reported a paroxysmal AF with fast ventricular response after the administration of fluticasone propionate, which resolved after discontinuation of the drug. Use of the Naranjo adverse-drug-reaction probability scale indicated a possible relationship between the patient's development of AF and fluticasone propionate therapy. More studies are needed to confirm the association between this arrhythmia and the use of high doses of inhaled corticosteroids. Data from this report already suggest that clinicians should be aware of the possibility of adverse cardiovascular reactions when corticosteroids are prescribed also as inhaled preparations.
心房颤动(AF)是临床实践中最常见的节律紊乱。几项病例报告和病例对照研究将这种情况与全身皮质类固醇的使用联系起来。然而,据我们所知,文献中尚无吸入皮质类固醇引起 AF 的病例报告。我们在这里描述了一例 15 岁男孩的病例,他在使用丙酸氟替卡松后出现阵发性 AF 伴快速心室反应,停药后缓解。使用 Naranjo 药物不良反应概率量表表明,患者发生 AF 与丙酸氟替卡松治疗之间可能存在关联。需要更多的研究来证实这种心律失常与使用大剂量吸入皮质类固醇之间的关联。本报告中的数据已经表明,当皮质类固醇也被开为吸入制剂时,临床医生应该意识到可能会出现不良心血管反应。